Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants

Jittamala P., Schilling WHK., Watson JA., Luvira V., Siripoon T., Ngamprasertchai T., Almeida PJ., Ekkapongpisit M., Cruz C., Callery JJ., Boyd S., Anunsittichai O., Hongsuwan M., Singhaboot Y., Pagornrat W., Tuntipaiboontana R., Kruabkontho V., Ngernseng T., Tubprasert J., Abdad MY., Keayarsa S., Madmanee W., Aguiar RS., Santos FM., Batty EM., Hanboonkunupakarn P., Hanboonkunupakarn B., Sookprome S., Poovorawan K., Imwong M., Taylor WRJ., Chotivanich V., Sangketchon C., Ruksakul W., Chotivanich K., Pukrittayakamee S., Dondorp AM., Day NPJ., Teixeira MM., Piyaphanee W., Phumratanaprapin W., White NJ.

DOI

10.1101/2022.10.17.22281161

Type

Preprint

Publication Date

19/10/2022

Permalink Original publication